I sent Replicel an e-mail regarding the starting date of their clinical trials in Germany. This is their response:
"We have been working out some manufacturing issues which has delayed our application to the PEI. We have to have these issues resolved and an application submitted before the end of the year."
If there are any questions you guys want me to ask post them here please.
I contacted them last week and that delay only affects the german trial. In Japan is gonna start in a brief time.
In addition, their trials of the skin rejuvenation and tendinosis are going as expected. The patent of their injection device too.
Expect a fast development in Europe if the other trials go well. Their income to spend in R+D will considerably raise.
01-19-2016 11:20 AM
Int
Quote:
Originally Posted by carvo
I contacted them last week and that delay only affects the german trial. In Japan is gonna start in a brief time.
In addition, their trials of the skin rejuvenation and tendinosis are going as expected. The patent of their injection device too.
Expect a fast development in Europe if the other trials go well. Their income to spend in R+D will considerably raise.
Well, that seems positive. Thank you for the update!
